STEM in Medicine: New ASCO 2026 data from the Phase 3 COMPETE trial reports that ¹⁷⁷Lu-edotreotide improved patient-reported quality of life versus everolimus for well-differentiated GEP-NETs, with fewer symptom/function declines and a higher share of clinically meaningful global health gains. Public Health & Biosecurity: WHO updates on the DRC/uganda Ebola outbreak note confirmed cases and deaths, while Kenya court action temporarily paused an Ebola quarantine center plan aimed at foreigners—raising questions about preparedness and who gets protected. Cancer Screening: GRAIL’s NHS-Galleri trial results presented at ASCO describe reduced Stage IV diagnoses in later screening rounds and higher detection when added to standard care, alongside discussion of how multi-cancer blood tests perform in real-world screening. Tech Policy & Privacy: Illinois passed laws limiting AI in teacher evaluations to administrative support only, and another bill standardizes mobile ID and driver’s licenses with tighter privacy rules. Cybersecurity & Infrastructure: A D.C.-area hearing focused on how the federal government can better help state and local governments deter cyber threats. Local Tech & Learning: A school district in Indiana moved forward with “bell-to-bell” phone restrictions compliance via updated device policy. Space & Energy: NASA shared details on lunar lander/rover contracts and a multi-phase plan for a permanent moon base. STEM for DC Readers: A D.C.-linked policy and infrastructure thread runs through the week’s coverage—cyber readiness, AI governance, and health tech all intersect with how communities in the District can plan, protect, and deliver services.